These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 25863005)
1. Gender differences in planning ability and hepatitis C virus among people who inject drugs. Scheidell JD; Khan MR; Clifford LM; Dunne EM; Keen LD; Latimer WW Addict Behav; 2015 Aug; 47():33-7. PubMed ID: 25863005 [TBL] [Abstract][Full Text] [Related]
2. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012. Kim NJ; Jin H; McFarland W; Raymond HF Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768 [TBL] [Abstract][Full Text] [Related]
3. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection. Artenie AA; Zang G; Daniel M; Fortier E; Jutras-Aswad D; Puzhko S; Bruneau J Int J Drug Policy; 2017 Sep; 47():239-243. PubMed ID: 28587944 [TBL] [Abstract][Full Text] [Related]
4. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C. Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study. McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. Eckhardt B; Winkelstein ER; Shu MA; Carden MR; McKnight C; Des Jarlais DC; Glesby MJ; Marks K; Edlin BR PLoS One; 2017; 12(5):e0177341. PubMed ID: 28542351 [TBL] [Abstract][Full Text] [Related]
7. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam. Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097 [TBL] [Abstract][Full Text] [Related]
9. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029 [TBL] [Abstract][Full Text] [Related]
10. HIV and Hepatitis C Virus Infection and Risk Behaviors Among Heterosexual, Bisexual, and Lesbian Women Who Inject Drugs in Australia. Iversen J; Dolan K; Ezard N; Maher L LGBT Health; 2015 Jun; 2(2):127-34. PubMed ID: 26790118 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey. Alaei A; Alaei K; Waye K; Tracy M; Nalbandyan M; Mutlu E; Cetin MK J Viral Hepat; 2017 Jun; 24(6):496-505. PubMed ID: 27925346 [TBL] [Abstract][Full Text] [Related]
13. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs. Williams LD; Mackesy-Amiti ME; Latkin C; Boodram B Drug Alcohol Depend; 2021 Apr; 221():108626. PubMed ID: 33689967 [TBL] [Abstract][Full Text] [Related]
14. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys. Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812 [TBL] [Abstract][Full Text] [Related]
15. Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan. Marotta PL; Gilbert L; Terlikbayeva A; Wu E; El-Bassel N Int J Drug Policy; 2018 Oct; 60():96-106. PubMed ID: 30219718 [TBL] [Abstract][Full Text] [Related]
16. Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms. Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F Int J Drug Policy; 2017 Aug; 46():28-33. PubMed ID: 28586700 [TBL] [Abstract][Full Text] [Related]
17. High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin. Rogers-Brown J; Sublett F; Canary L; Rein DB; Bhat M; Thompson WW; Vellozzi C; Asher A Subst Use Misuse; 2022; 57(5):665-673. PubMed ID: 35240921 [TBL] [Abstract][Full Text] [Related]
18. Syringe sharing among people who inject drugs in London, Canada. Scheim AI; Bardwell G; Rachlis B; Mitra S; Kerr T Can J Public Health; 2018 Apr; 109(2):174-182. PubMed ID: 29981046 [TBL] [Abstract][Full Text] [Related]
19. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Korthuis PT; Feaster DJ; Gomez ZL; Das M; Tross S; Wiest K; Douaihy A; Mandler RN; Sorensen JL; Colfax G; McCarty D; Cohen SE; Penn PE; Lape D; Metsch LR Addict Behav; 2012 Apr; 37(4):552-5. PubMed ID: 22209655 [TBL] [Abstract][Full Text] [Related]
20. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]